Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01173
|
|||||
| Drug Name |
Sodium chloride
|
|||||
| Synonyms |
7647-14-5; Adsorbanac; Arm-A-Vial; CCRIS 982; Caswell No 754; Colyte; Common salt; Dendritis; Extra Fine 200 Salt; Extra Fine 325 Salt; Flexivial; Gingivyl; HG blending; Halite; Hypersal; Hyposaline; Iodized salt; NaCl; Natriumchlorid; Purex; Rock salt; SS salt; Saline; Salt; Salt (ingredient); Sea salt; Slow Sodium; Sodium chloric; Sodium chloride (Na4Cl4); Sodium chloride (NaCl); Sodium chloride brine, purified; Sodium monochloride; Table salt; Top flake; Trisodium trichloride; White crystal; sodium chloride; sodiumchloride; sterling
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Severe mood disorders [ICD11: 6A8Z] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
ClNa
|
|||||
| Canonical SMILES |
[Na+].[Cl-]
|
|||||
| InChI |
InChI=1S/ClH.Na/h1H;/q;+1/p-1
|
|||||
| InChIKey |
FAPWRFPIFSIZLT-UHFFFAOYSA-M
|
|||||
| CAS Number |
CAS 7647-14-5
|
|||||
| Pharmaceutical Properties | Molecular Weight | 58.44 | Topological Polar Surface Area | 0 | ||
| Heavy Atom Count | 2 | Rotatable Bond Count | 0 | |||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 1 | |||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:26710
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | NKCC1 | Transporter Info | Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1 | Substrate | [2] | |
| NKCC2 | Transporter Info | Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2 | Substrate | [3] | ||
| OCT-3 | Transporter Info | Organic cation transporter 3 | Substrate | [4] | ||
| References | ||||||
| 1 | Sodium chloride was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Expression of the sodium potassium chloride cotransporter (NKCC1) and sodium chloride cotransporter (NCC) and their effects on rat lens transparency. Mol Vis. 2010 May 4;16:800-12. | |||||
| 3 | Upregulation of renal sodium transporters in D5 dopamine receptor-deficient mice. Hypertension. 2010 Jun;55(6):1431-7. | |||||
| 4 | Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation. J Neurosci. 2004 Mar 17;24(11):2846-51. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.